ConductScience.org, home

Paper41300764

The miR-200 Family in Non-Small-Cell Lung Cancer: Molecular Mechanisms, Clinical Applications, and Therapeutic Implications.

Kobayashi N and 6 others. Genes (Basel), 2025. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. The miR-200 Family in Non-Small-Cell Lung Cancer: Molecular Mechanisms, Clinical Applications, and Therapeutic Implications. Papers, record 41300764. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41300764

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The miR-200 Family in Non-Small-Cell Lung Cancer: Molecular Mechanisms, Clinical Applications, and Therapeutic Implications.
PubMed
Journal
Genes (Basel)
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
1.72, provisional
iCite
Revised in PubMed
2025-11-30
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kobayashi NNobuakihttps://orcid.org/0000-0002-7064-320X
2Kajita YYukihito
3Yang FFangfei
4Fukuda NNobuhiko
5Somekawa KKohei
6Kaneko AAyami
7Katakura SSeigo

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, Non-Small-Cell LungMajor topic
MicroRNAsMajor topic
Lung NeoplasmsMajor topic
Humans
Epithelial-Mesenchymal Transition
Biomarkers, Tumor
Zinc Finger E-box-Binding Homeobox 1
Gene Expression Regulation, Neoplastic
Zinc Finger E-box Binding Homeobox 2

Source PubMed

Download CSV of topics

References70

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136140280Lipid Nanoparticles as Delivery Vehicles for Inhaled Therapeutics.Biomedicines2022https://conductscience.org/library/papers/36140280PubMed
239766891The Impact of Bevacizumab and miR200c on EMT and EGFR-TKI Resistance in EGFR-Mutant Lung Cancer Organoids.Genes (Basel)2024https://conductscience.org/library/papers/39766891PubMed
327917453Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors.Invest New Drugs2017https://conductscience.org/library/papers/27917453PubMed
428870611Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study.Lancet Oncol2017https://conductscience.org/library/papers/28870611PubMed
532238921Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours.Br J Cancer2020https://conductscience.org/library/papers/32238921PubMed
631275609Combinatorial perturbation analysis reveals divergent regulations of mesenchymal genes during epithelial-to-mesenchymal transition.NPJ Syst Biol Appl2019https://conductscience.org/library/papers/31275609PubMed
728084458Targeting the miR-200c/LIN28B axis in acquired EGFR-TKI resistance non-small cell lung cancer cells harboring EMT features.Sci Rep2017https://conductscience.org/library/papers/28084458PubMed
818485877The epithelial-mesenchymal transition generates cells with properties of stem cells.Cell2008https://conductscience.org/library/papers/18485877PubMed
918292307Selective blockade of microRNA processing by Lin28.Science2008https://conductscience.org/library/papers/18292307PubMed
1020696752Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer.Mol Cancer Res2010https://conductscience.org/library/papers/20696752PubMed
1129634943T Cell Dysfunction in Cancer.Cancer Cell2018https://conductscience.org/library/papers/29634943PubMed
1229792572GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics.Nucleic Acid Ther2018https://conductscience.org/library/papers/29792572PubMed
1326851185Epithelial-Mesenchymal Transition Is Associated with a Distinct Tumor Microenvironment Including Elevation of Inflammatory Signals and Multiple Immune Checkpoints in Lung Adenocarcinoma.Clin Cancer Res2016https://conductscience.org/library/papers/26851185PubMed
1420847327The microRNA spectrum in 12 body fluids.Clin Chem2010https://conductscience.org/library/papers/20847327PubMed
1529874593Small-Molecule Inhibitors Disrupt let-7 Oligouridylation and Release the Selective Blockade of let-7 Processing by LIN28.Cell Rep2018https://conductscience.org/library/papers/29874593PubMed
1634136077Trisubstituted Pyrrolinones as Small-Molecule Inhibitors Disrupting the Protein-RNA Interaction of LIN28 and Let-7.ACS Med Chem Lett2021https://conductscience.org/library/papers/34136077PubMed
1737589246Pharmacokinetics and Pharmacodynamics of GalNAc-Conjugated siRNAs.J Clin Pharmacol2024https://conductscience.org/library/papers/37589246PubMed
1821874049Dynamic epigenetic regulation of the microRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesis.Oncogene2012https://conductscience.org/library/papers/21874049PubMed
1934884985The miR-200 Family of microRNAs: Fine Tuners of Epithelial-Mesenchymal Transition and Circulating Cancer Biomarkers.Cancers (Basel)2021https://conductscience.org/library/papers/34884985PubMed
2025348003Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression.Nat Commun2014https://conductscience.org/library/papers/25348003PubMed

See all 70 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
42909957Beyond immune surveillance: IFN-γ and PD-L1 as shapers of tumor plasticity in Non-Small Cell Lung Cancer (NSCLC).Front Immunol2026https://conductscience.org/library/papers/42909957PubMed
42882453OVO-like Proteins in Cancer, Immunity, and Inflammation.Cells2026https://conductscience.org/library/papers/42882453PubMed
42652120Identification of a CSC-Associated miRNA Signature in NSCLC and Functional Characterization of hsa-let-7a-3p.Biomedicines2026https://conductscience.org/library/papers/42652120PubMed
42615693Exosomes and lung cancer: Biogenesis, pathogenic mechanisms, biomarkers, and therapeutic applications.J Int Med Res2026https://conductscience.org/library/papers/42615693PubMed
42352916A Multi-Level miRNA Regulatory Network Associated with IRF1 Expression in Non-Small Cell Lung Cancer: In Silico Identification of Candidate Biomarkers for Immunotherapy Response.Int J Mol Sci2026https://conductscience.org/library/papers/42352916PubMed
42338902Comparable Efficacy of Chitosan/miR-200b-3p and Lipofectamine/miR-200b-3p Delivered by Pluronic F127 Hydrogel to Facilitate Diabetic Wound Healing.Int J Nanomedicine2026https://conductscience.org/library/papers/42338902PubMed
41882712MicroRNA-regulated signaling and tumor microenvironment modulation in lung cancer: mechanistic insights and translational opportunities.Cancer Cell Int2026https://conductscience.org/library/papers/41882712PubMed

Download CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
ZEB16935PubTator's text mininghttps://conductscience.org/library/genes/6935NCBI Gene
ZEB29839PubTator's text mininghttps://conductscience.org/library/genes/9839NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41300764

GET https://conductscience.org/api/papers/v1/41300764/references?page=2